Member Info for doze

They could be but I think of AVCT as the ARM chip in big pharma. Todays AffyXell RNS is the foot in the door for therapy in vivo- possibly a long haul but how soon before a phase 1? Successful phase 1 could have many firms knocking on the door.

Cytiva sent the spec s for the LFT to AVCT, they will get a licence fee for every test produced by manufacturers which AVCT will find. That is my take on the matter. Danaher do the tests development https://www.danaher.com/how-we-work/danaher-business-system they are not a bioscience/pharma company. They wouldn't have clue what to do with affimers.

What does this tell us about solar power?

That is simple.

The story of the revolution in Afghan heroin production shows us just how transformative solar power can be.

Don't imagine this is some kind of benign "green" technology.

Solar is getting so cheap that it is capable of changing the way we do things in fundamental ways and with consequences that can affect the entire world.

https://www.bbc.co.uk/news/science-environment-53450688

I meant take the panel trade off whoever not the opium. You are not going to stop either.

Solar panels on trucks in Afghan for opium trade. Makes you think we are under attack with opium as some sort of long time retribution. Would be a good trade for VDTK.

https://seekingalpha.com/article/4360753-newmont-how-to-profit-from-potential-end-of-king-dollar

Eighteen; if interest rates ever go up then the number of spreadbetters will go down and returns for IG unless they do not equate leverage to market rates for borrow. I suggest to IG that they should not charge interest at all as they can make money on margin anyway and it will give them a longterm model. Low interest rates do support the high yield from dividend.

I hope this doesn't carry on in the JV - pesky Bezos

Intellectual Property will not be given up by AVCT as key to growing. This is making a deal on the therapy side difficult because big pharma will want to exploit the IP.

This is also what Ophidian said

Here is the Timeline I posted (please note 1-6 are completed so not reproduced here)

7. Additional batches made again at pilot scale to clinical standards for first time clinical evaluation. Supplied Wk3/Wk4 June Time to complete 21-28 Days (end of July)
8. In parallel with clinical programme; Scale up to production scale. Include Tech transfer and validation batches (again put on stability to generate data)
9. Evaluate data from clinical programme (establishes the Selectivity and Sensitivity of the test) July Wk.2s/wk3/wk4
10. Generate the Regulatory dossier including clinical data, stability data, development data and supporting data from early designs Wk2/wk3/wk4 July
11. Submit Regulatory dossier and if not already ongoing be manufacturing launch stocks 1st August
12. Get approval Wk3 August
13. Start selling Wk3/4 August

So to answer your question - right now I expect the clinical validation is taking place and in parallel, Stability data is being generated and compiled into report format,. Additionally I expect tech transfers and scale up activity is also ongoing. You will note - I was not expecting any RNS on LFD before August aside from potentially an announcement of manufacturing partners.

Given what we have heard in the press about the prevalence of the disease it is possible it may take longer to complete Clinical validations due to a shortage of ill people. This was also noted by the company in the videoconference from Cytiva. I don't know that that is the case or not but it's worth noting.

I thought bad PR not putting that first-how many might not read tio the end and what is most important? LFT is surely? Hope all validates smoothly.

https://seekingalpha.com/news/3592898-doe-unveils-funding-plans-for-hydrogen-research-projects?utm_medium=email&utm_source=seeking_alpha&mail_subject=cat-doe-unveils-funding-plans-for-hydrogen-research-projects&utm_campaign=rta-stock-news&utm_content=link-1

The whole world has found no effective control to fight covid19. The nations with a bit of fat have ordered lockdown and track and trace which has been effective as far as governments can afford to keep it going but children suffer. It has been an education to me how much the schooling of children is an essential mental health function aswell as education so it goes without saying that we must all get back to normal and only AVCT has the means of delivering normal.
The internet has brought the dangers of a pandemic to the fore. It is a legitimate fear but in the past death and disease was not a political function. In the current situation lockdown has caused as much damage as an untrammelled pandemic and it maybe that if political will for control persists we may see billions spent on a saliva test provided by AVCT as the best solution or it maybe with the control measures and social distancing the nations that would buy the LFA are not going to bother. Either way the governments of the world will posture to cover themselves and they and businesses will decide how many tests it is prudent to buy when tests are available. Antibody test are useless. Everything is really pretty obvious but vested interests always have to hide behind blather.

I haven't seen any comments here on the announcement which will most likely have been the xcaus of todays sp rise.

On the 1st August employers will be responsible for deciding if workers will come back. The Government has not said if civil servants will be required to come in to work. This is the reason for the rise today-will testing be a feature of return to work- will employees be left to decide if they want to return? Will they get a free LFA as a reward if they do? Hopefully our test will be on the market for them soon, if not on 1/8.
https://www.bbc.co.uk/news/uk-53441912

https://en.calameo.com/read/006113385393912394987?page=10

added this link for last page in case people miss it.

Does Avacta distribute the orders amongst the manufacturers? How will it work to be fair to all who have agreed to make the LFAs?

important announcement: remember to wear facemask in Sainsbury tomorrow and hospitals and public transport.
I would expect if a 10 minute antigen test were available that hospitals, carehomes and doctors surgeries would be behind a test wall.

Optimisation implies tweeking improvements then how long does say a couple hundred LFA 10 minute tests executed by known status recipients take: half a day or less? to clear regulatory requirements? Well it would if I was running them. Anyway if in house trials are good AVCT will begin manufacture ahead of approval as once line is set up it needs to be 24/7 if orders are in.

Well there is great potential for producing more cheaply and selling direct to the public so shows the small independants are worried.

LFAs detect spikes & skunks have spikes. Both can operate in stenchy environment.